ClinicalTrials.gg
Sign In

Small Cell Lung Carcinoma clinical trials

The registry lists 1,301 studies for Small Cell Lung Carcinoma across more than 10 countries. 365 are recruiting or about to start. 879 of them are mainly about Small Cell Lung Carcinoma (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-12.

ClinicalTrials.gov finds 9,770 studies for Small Cell Lung Carcinoma. How that becomes 1,300 here

This page counts the studies the registry files under Small Cell Lung Carcinoma, and those it files under no condition that list Small Cell Lung Carcinomathemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count

  1. 9,770Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
  2. −31List Small Cell Lung Carcinoma as a condition, but the registry did not file them under itMost often written as “Small Cell Lung Cancer Extensive Stage” (6), “Extensive Stage Small Cell Lung Carcinoma” (3), and “Extensive Disease Small Cell Lung Cancer” (3). The registry filed 1 of them under no condition at all, and the others under other conditions only, most often Neoplasms (6) and Carcinoma, Non-Small-Cell Lung (6).
  3. −8,439Match it another way200 name it in the title, 26 in a keyword, and 8,213 by a synonym or other text the search reads.
  4. 1,300The count on this page94 of them list Small Cell Lung Carcinoma in their own words; the registry filed them under no condition.

Get an email when these change. Save the Small Cell Lung Carcinoma studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
479
Recruiting
263
Terminated
154
Status unknown
147
Active, not recruiting
105
Not yet recruiting
91

Phase

Phase 2
640
Phase 1
420
Phase 3
140
Phase 4
12
Early Phase 1
10

Where

United States
629
China
365
Spain
141
France
120
Korea, Republic of
107
Canada
96

Who runs them

National Cancer Institute (NCI) (65) · AstraZeneca (24) · Amgen (19) · AbbVie (18) · GlaxoSmithKline (15) · Shanghai Pulmonary Hospital, Shanghai, China (15) · Memorial Sloan Kettering Cancer Center (13) · Hoffmann-La Roche (13)

What is being tested here

Drugs under test in Small Cell Lung Carcinoma studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Adebrelimab15218
Anlotinib10325
Durvalumab9430
AMG 7579618
Irinotecan8738
Etoposide8837
PM 011838415
Alveltamig717
Carboplatin6433
Tislelizumab6111

Drug classes tested here Immune checkpoint inhibitors 72 open · Tyrosine kinase inhibitors (TKIs) 27 open · Antibody-drug conjugates (ADCs) 5 open · Antimitotic agents 4 open · PARP inhibitors 4 open

Coming up

58phase 3 studies under way
132studies finish main data collection within a year15 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 263 Small Cell Lung Carcinoma studies recruiting now, 173 (66%) set no upper age limit and 66 (25%) stop at 75 or younger. 3 (1%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 8 (3%) take healthy volunteers.

Recruiting studies that take each age, of 263
AgeWomenMen
101 (<1%)1 (<1%)
18256 (97%)256 (97%)
30260 (99%)260 (99%)
40260 (99%)260 (99%)
50262 (100%)262 (100%)
65263 (100%)263 (100%)
75256 (97%)256 (97%)
85188 (71%)188 (71%)

Across all 1,301 studies, recruiting or not: 19% stop at 75 or younger and 1% at 65; 3% take children; <1% are for women only and <1% for men only; 2% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Small Cell Lung Carcinoma studies take

Of 204 phase 2 interventional studies under Small Cell Lung Carcinoma, half reached primary completion within 46 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 146 mo29–64 · 143 studies44 mo29–63 · 111 studies—
Phase 1/254 mo44–97 · 98 studies54 mo43–74 · 71 studies—
Phase 246 mo29–84 · 204 studies35 mo18–44 · 54 studies53 mo36–87 · 150 studies
Phase 341 mo31–48 · 68 studies34 mo30–44 · 55 studies—
Interventional, no phase52 mo25–73 · 47 studies—52 mo26–73 · 45 studies
Observational77 mo47–… · 62 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Started recruiting5

Results posted2

Stopped3

Newly registered14

Show 9 more

Studies

Recruiting first, then most recently updated. Showing 50 of 1,301. Browse all 1,301 → or search them.